Professor Gilles Lemesle

Back

Professor Gilles Lemesle

Lille University Hospital, Lille (France)

Presentations

Overview of the risk of myocardial infarction in patients with aortic stenosis: insights from the VALVENOR Registry.

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Advancing knowledge in valvular heart disease: the role of registries

Access

STEMI and stroke networks: experience from the North of France.

Event: ESC Congress 2017

Topic: Infarction acute phase non STEMI

Session: Challenges and opportunities of establishing reperfusion networks for ST-segment elevation myocardial infarction (STEMI) and for acute stroke

Access

Incident myocardial infarction, very late stent thrombosis and their related mortality in stable coronary artery disease outpatients: 5-year follow-up of the CORONOR registry

Event: ESC Congress 2017

Topic: Angina pectoris stable

Session: Stable CAD

Access

Aspirin versus no aspirin on top of vitamin K antagonists in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischaemic and bleeding events

Event: ESC Congress 2016

Topic: Antithrombotic agents

Session: Tailoring antithrombotics according to bleeding risk

Access

Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: prevalence, correlates and prognostic impact (from the CORONOR study)

Event: ESC Congress 2016

Topic: Adjunctive medical therapy

Session: Adjunctive medical therapy in coronary artery disease

Access

Clopidogrel use as single antiplatelet therapy in outpatients with stable coronary artery disease: prevalence, correlates and association with prognosis (from the CORONOR study)

Event: ESC Congress 2016

Topic: Thrombosis and platelets

Session: Antiplatelet therapy

Access

ESC 365 is supported by

Explore sponsored resources

Professor Gilles Lemesle Follow

Contributor content

Overview of the risk of myocardial infarction in patients with aortic stenosis: insights from the VALVENOR Registry.

STEMI and stroke networks: experience from the North of France.

Incident myocardial infarction, very late stent thrombosis and their related mortality in stable coronary artery disease outpatients: 5-year follow-up of the CORONOR registry

Aspirin versus no aspirin on top of vitamin K antagonists in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischaemic and bleeding events

Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: prevalence, correlates and prognostic impact (from the CORONOR study)

Clopidogrel use as single antiplatelet therapy in outpatients with stable coronary artery disease: prevalence, correlates and association with prognosis (from the CORONOR study)

ESC 365 is supported by

Professor Gilles Lemesle